Ipamorelin 10mg Peptides
Precision begins with materials you can trust.
Better Molecule Ipamorelin is a lyophilized peptide vial designed for controlled laboratory work where consistency and clarity of handling matter. This research-grade preparation contains a total of 10mg per vial of the selective growth hormone secretagogue peptide ipamorelin, presented as a stable, freeze-dried powder for dependable reconstitution and method development.
- Each vial contains 10mg of Ipamorelin, a selective growth hormone secretagogue peptide widely used in controlled studies of growth hormone release, receptor selectivity, and downstream signaling.
Developed for non-clinical applications, this format supports reliable preparation and repeatable experimental workflows. The lyophilized presentation assists with controlled reconstitution by qualified personnel following institutional protocols and suitable sterile technique. Researchers value the clean handling characteristics of this vial format for assay design, pilot work, and ongoing method optimization where lot-to-lot dependability is important.
Ipamorelin is commonly selected for projects exploring GH-axis mechanisms, time-course behavior, and receptor-specific activity profiles. When properly reconstituted with an appropriate sterile diluent, the solution integrates readily into standard laboratory setups. Store, aliquot, and handle according to your laboratorys procedures to maintain integrity across the duration of your study. Not for human consumption or veterinary use.
Every Better Molecule peptide reflects a disciplined approach to quality. Vials are produced in the USA under strict controls, lot-tracked, and supported by documentation to help verify identity and purity. Each batch is subject to analytical testing with results available per lot (COA), reinforcing confidence in the material youre working with. Packaging is clean, professional, and designed to protect the contents from manufacture through delivery, with careful handling at each step.
Research Use Only. Not for human consumption. Not a drug, food, or cosmetic. For qualified institutions and laboratory professionals performing approved research protocols. Better Molecule prioritizes purity, consistency, and transparency so your focus stays on the workexact, repeatable, and aligned with rigorous scientific standards.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Ipamorelin?
Ipamorelin is a growth-hormone secretagogue that acts primarily through the ghrelin receptor pathway. It is often described as more selective than older secretagogues because it is studied for GH release with less interest in off-target hormone stimulation. For product copy, it should be described as a research peptide for endocrine signaling studies.
What is Ipamorelin typically studied for?
Ipamorelin is typically studied for endogenous growth-hormone release, GH/IGF-1-axis signaling, recovery-related models, and pulse-based endocrine research. It is commonly paired with GHRH analogs in blend products because those two signaling routes are often examined together.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Better Molecule are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
